EU Business Round-Up: ColdZyme Heading To MENA, Kerry Expands Probiotics Offering, Galenica Launches Vita-Merfen
Latest EU company news: Enymatica strikes deal to take its ColdZyme common cold product into MENA; Ireland's Kerry snaps up Canadian probiotics specialist Bio-K Plus; and Switerland's Galenica relaunches Vita-Merfen after a five-year absence.
You may also be interested in...
Latest European Probiotics News: Probi and BioGaia post earnings, with differing results, while Kerry seeks to expand with Spain's Biosearch.
With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.
Reckitt is refocusing its consumer health portfolio by offloading the troubled Scholl brand and acquiring fast-growing US topical analgesic Biofreeze.